FUNDACION AGENCIA ARAGONESA PARA LA INVESTIGACION Y EL DESARROLLO -  

Ranking results:

Past rankings:

2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2014-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 4
As coordinator: 0
As participant: 3
Sole participant: 1
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 6.846.157 0 1
2020 0 2.509.342 0 1
2018 170.122 0 170.122 1
2014 0 110.000 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ACCIONA1
AERNNOVA COMPOSITES1
AERNNOVA ENGINEERING SOLUTIONS1
ASSOCIAZIONE FRASCATI SCIENZA1
BIOSPHERE1
CONSORCIO AERODROMO AEROPUERTO DE TERUEL1
ESCIENCIA EVENTOS CIENTIFICOS SL1
EUROPEAN COMPOSIT RECYCLING TECHNOLOGY AS1
EVOENZYME SL1
FUNDACION AITIIP1
GENEURO INNOVATION SAS1
INSERM TRANSFERT1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD1
KLINICKI BOLNICKI CENTAR RIJEKA1
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS1
SPECIFIC POLYMERS1
SPECIFIC POLYMERS ANALYSES1
TECHNISCHE UNIVERSITEIT DELFT1
UNIVERSIDAD DE CADIZ1
UNIVERSIDAD DE ZARAGOZA1
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA1

Constancy:

Total number of partners: 22
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 22
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2022-07-01SARS-CoV-2-induced activation of pathogenic endogenous retrovirus envelope HERV-W: towards personalized treatment of COVID-19 patients HERVCOVparticipant6.846.1579
2020-05-01Apply ligninases to resolve end-of-life issues of thermoset composite plastics BIZENTEparticipant2.509.34213
2018-04-01Beta-lactams for Tuberculosis Treatment BLMs 4 TBcoordinator170.1221
2014-05-01European Reseearchers Night: Researchers in Real Life. ESCparticipant110.0003